Position in AMGN
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$3,752,287
+$438,212 QoQ
Shares Held
10,362
+10.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
#964
of 3,139 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Csenge Advisory Group holds $34,699,600 across 10 Drug Manufacturers - General names. AMGN ranks #4 (10.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,327 | $6,389,364 | |
| 2 | ABBV |
AbbVie Inc.
|
25,158 | $6,330,759 | |
| 3 | JNJ |
Johnson & Johnson
|
18,196 | $4,621,238 | |
| 4 | AMGN |
Amgen Inc
This page
|
10,362 | $3,752,287 | |
| 5 | PFE |
Pfizer Inc
|
154,984 | $3,732,014 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
22,416 | $2,832,037 | |
| 7 | NVS |
Novartis AG
|
16,110 | $2,524,759 | |
| 8 | GSK |
GSK plc
|
41,506 | $2,175,744 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,752,287 | 10,362 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $3,314,075 | 9,419 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $3,445,919 | 10,528 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $2,378,663 | 8,429 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $1,782,197 | 6,383 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,976,161 | 6,343 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $1,600,068 | 6,139 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $2,280,280 | 7,077 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,139,032 | 6,846 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $1,918,875 | 6,749 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,996,842 | 6,933 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,402,120 | 5,217 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $624,320 | 2,812 | Shares | Sole | 2023-07-20 | |
| 2023-03-31 | $626,857 | 2,593 | Shares | Sole | 2023-05-01 | |
| 2022-12-31 | $641,629 | 2,443 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $533,972 | 2,369 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $621,144 | 2,553 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $533,696 | 2,207 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $545,327 | 2,424 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $517,164 | 2,432 | Shares | Sole | 2021-10-20 | |
| 2021-06-30 | $590,850 | 2,424 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $505,581 | 2,032 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $636,878 | 2,770 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $910,401 | 3,582 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $862,068 | 3,655 | Shares | Sole | 2020-07-17 | |
| 2020-03-31 | $404,040 | 1,993 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||